Filing Details

Accession Number:
0001225208-14-025378
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-12-17 18:15:12
Reporting Period:
2014-12-15
Filing Date:
2014-12-17
Accepted Time:
2014-12-17 18:15:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
9892 Bard C R Inc BCR Surgical & Medical Instruments & Apparatus (3841) 221454160
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1463423 C Jim Beasley C/O C. R. Bard, Inc.
730 Central Avenue
Murray Hill NJ 07974
Group President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-12-15 3,271 $166.63 27,625 No 4 F Direct
Common Stock Acquisiton 2014-12-16 8,656 $84.58 36,281 No 4 M Direct
Common Stock Acquisiton 2014-12-16 5,978 $97.69 42,259 No 4 M Direct
Common Stock Disposition 2014-12-16 1,066 $168.45 41,193 No 4 S Direct
Common Stock Disposition 2014-12-16 3,700 $166.71 37,493 No 4 S Direct
Common Stock Disposition 2014-12-16 9,868 $167.65 27,625 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option (Right to Buy) Disposition 2014-12-16 5,978 $0.00 5,978 $97.69
Common Stock Option (Right to Buy) Disposition 2014-12-16 8,656 $0.00 8,656 $84.58
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
11,955 2022-12-12 No 4 M Direct
8,656 2021-12-14 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 3,090 Indirect 401(k) Plan
Footnotes
  1. Shares withheld to pay taxes upon vesting of restricted stock units granted under the Company's 2003 Long Term Incentive Plan.
  2. Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan.
  3. Represents the weighted average sales price for price increments ranging from $168.15 to $168.94. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
  4. Represents the weighted average sales price for price increments ranging from $166.13 to $167.11. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
  5. Represents the weighted average sales price for price increments ranging from $167.13 to $168.09. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
  6. Includes 8.7 shares acquired under the Company's 401(k) Plan from February 11, 2014 to October 31, 2014.
  7. Options granted under 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated).
  8. Of this option grant 5,978 options vested on December 12, 2014 and the remaining options vest in two annual installments beginning on December 12, 2015.
  9. Options granted under the 2003 Long Term Incentive Plan of C. R. Bard, Inc.
  10. Of this option grant 8,656 options vested on December 14, 2014 and the remaining 8,656 options vest on December 14, 2015.